P&G to Acquire Thorne for $3.8 Billion, Signaling Continued Growth in the Supplement Industry
- Share
- publisher
- FORNUTRA
- Issue Time
- Aug 17,2026
Summary
P&G has agreed to acquire Thorne for $3.8 billion, highlighting growing investment in premium, science-backed supplement brands and continued growth in the global supplement industry.

Procter & Gamble (P&G) has announced an agreement to acquire Thorne, a science-focused health and wellness brand, for approximately $3.8 billion in cash. The transaction, disclosed on August 4, 2026, is expected to close in the fourth quarter of 2026, subject to regulatory approvals and customary closing conditions. The move deepens P&G's presence in the premium supplement category and adds an established, science-backed brand to its personal health care portfolio. For the wider dietary supplement industry, the deal is a clear signal that global consumer goods leaders continue to see long-term value in specialized nutrition and preventive wellness. The agreement brings together one of the world's largest consumer goods companies and a premium supplement brand known for its science-led approach to nutrition. It ranks among the largest transactions in the supplement industry in recent years and highlights how large consumer companies are repositioning their portfolios around health and wellness. Founded in 1984, Thorne has built a reputation as a science-backed supplement brand serving both consumers and healthcare practitioners. Its portfolio spans vitamins and minerals, sports nutrition, healthy aging, women's health, and personalized wellness. Thorne's premium positioning and emphasis on research-driven formulations have made it a notable asset in a supplement market where credibility and ingredient transparency increasingly shape purchasing decisions. The P&G–Thorne agreement is part of a broader pattern of large consumer goods companies entering the health and wellness industry. As demand for specialized nutrition grows, established companies are seeking brands that offer credible, science-driven products and direct relationships with health-conscious consumers. Consumer interest is shifting from general multivitamins toward more targeted nutrition. Several areas are among the fastest-growing sources of demand: This shift toward self-care and proactive well-being has expanded the supplement market well beyond its traditional audience and drawn the attention of major consumer brands. Modern consumers pay close attention to ingredient quality, formulation expertise, and product transparency. Brands that combine scientific credibility with rigorous quality control and targeted nutrition are well positioned in this environment. For large companies, acquiring premium supplement brands offers a faster route into a category where trust and science-backed product development matter more than mass-market reach alone. The transaction carries implications for supplement brands, supplement manufacturers, and the broader health and wellness industry. Large consumer companies entering the supplement market tend to bring increased investment, stronger competition, and greater brand consolidation. More capital flows into the category as established players expand their health and wellness portfolios. Deeper resources raise the bar for product quality, marketing, and distribution across the supplement market. High-quality, science-backed supplement brands are likely to attract more attention from strategic buyers and investors. A more competitive market typically raises expectations around innovation. Brands are likely to place greater emphasis on: As competition intensifies, supplement brands are also paying closer attention to their supply chains. Custom formulation and R&D support, flexible dosage forms, quality control, ingredient sourcing, regulatory support, and scalable manufacturing are increasingly important. This is where supplement OEM and ODM manufacturers play a central role — helping brands translate market opportunities into compliant, market-ready products. Several areas are likely to shape the next phase of the supplement industry: As a supplement OEM and ODM manufacturer, FORNUTRA closely follows how global demand for custom formulations, functional ingredients, innovative dosage forms, quality manufacturing, and regulatory compliance is evolving. The P&G–Thorne agreement reinforces a trend the company has observed across the supplement market: brands are increasingly seeking partners that can support science-driven product development from concept to shelf. From custom formulation and R&D to scalable manufacturing and regulatory support, FORNUTRA helps supplement brands bring compliant, science-driven products to market.
P&G Announces $3.8 Billion Acquisition of Thorne
Key Details of the Acquisition
Thorne's Position in the Supplement Market
Why Major Consumer Brands Are Investing in Supplements
Growing Demand for Specialized Nutrition
Premium and Science-Driven Supplements
What the Acquisition Could Mean for the Supplement Industry
More Investment in Supplement Brands
Greater Focus on Innovation and Product Development
Opportunities for Supplement Manufacturers
What Supplement Brands Should Watch Next
FORNUTRA's Perspective on the Evolving Supplement Market